[1] HOY D, MARCH L, BROOKS P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968-974.
[2] VOS T, FLAXMAN A D, NAGHAVI M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380 (9859):2163-2196.
[3] Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260-1344.
[4] MANCHIKANTI L, SINGH V, DATTA S, et al. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician. 2009; 12(4):E35-E70.
[5] GORTH DJ, SHAPIRO IM, RISBUD MV. Discovery of the drivers of inflammation induced chronic low back pain: from bacteria to diabetes. Discov Med. 2015;20(110):177-184.
[6] HUGHES SP, FREEMONT AJ, HUKINS DW, et al. The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br. 2012;94(10):1298-304.
[7] CHEN Z, LI X, PAN F, et al. A retrospective study: does cigarette smoking induce cervical disc degeneration? Int J Surg. 2018;53:269-273.
[8] WANG F, CAI F, SHI R, et al. Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthritis Cartilage. 2016;24(3):398-408.
[9] JIN LY, SONG XX, LI XF. The role of estrogen in intervertebral disc degeneration. Steroids. 2020;154:108549.
[10] CLOUET J, FUSELLIER M, CAMUS A, et al. Intervertebral disc regeneration:From cell therapy to the development of novel bioinspired endogenous repair strategies. Adv Drug Deliv Rev. 2019; 146:306-324.
[11] 李秋江,房晓敏,王胤斌,等.干细胞治疗椎间盘退变研究现状和趋势的文献计量学分析[J].中国组织工程研究,2021,25(31):5000-5011.
[12] 余城墙,张宇,谢程欣,等.椎间盘退变分子生物学机制及再生治疗的优势与未来[J].中国组织工程研究,2019,23(30):4889-4896.
[13] FRAUCHIGER DA, TEKARI A, WöLTJE M, et al. A review of the application of reinforced hydrogels and silk as biomaterials for intervertebral disc repair. Eur Cell Mater. 2017;34:271-290.
[14] 孟真,张永兴,赵庆华.水凝胶人工髓核应用于椎间盘退变的研究进展[J].中国矫形外科杂志,2015,23(19):1790-1792.
[15] 石坤,黄勇,黄雷震,等.水凝胶再生修复退变椎间盘的研究进展[J].中国修复重建外科杂志,2020,34(3):275-284.
[16] 陈亮,姚峰.载细胞水凝胶在椎间盘修复中的应用[J].医学综述, 2017,23(18):3651-3655.
[17] BORRELLI C, BUCKLEY CT. Injectable disc-derived ECM hydrogel functionalised with chondroitin sulfate for intervertebral disc regeneration. Acta Biomater. 2020;117:142-155.
[18] GHANNAM M, JUMAH F, MANSOUR S, et al. Surgical anatomy, radiological features, and molecular biology of the lumbar intervertebral discs. Clin Anat. 2017;30(2):251-266.
[19] WANG J, HUANG L, HUANG Y, et al. Therapeutic effect of the injectable thermosensitive hydrogel loaded with SHP099 on intervertebral disc degeneration. Life Sci. 2021;266:118891.
[20] KHAN AN, JACOBSEN HE, KHAN J, et al. Inflammatory biomarkers of low back pain and disc degeneration: a review. Ann N Y Acad Sci. 2017; 1410(1):68-84.
[21] URBAN JP, ROBERTS S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120-130.
[22] ROUGHLEY PJ, ALINI M, ANTONIOU J. The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. Biochem Soc Trans. 2002;30(Pt 6):869-874.
[23] MALANDRINO A, LACROIX D, HELLMICH C, et al. The role of endplate poromechanical properties on the nutrient availability in the intervertebral disc. Osteoarthritis Cartilage. 2014;22(7):1053-1060.
[24] GARCíA-COSAMALóN J, DEL VALLE ME, CALAVIA MG, et al. Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain? J Anat. 2010;217(1):1-15.
[25] RAJ PP. Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Prac. 2008;8(1):18-44.
[26] XU H, MEI Q, XU B, et al. Expression of matrix metalloproteinases is positively related to the severity of disc degeneration and growing age in the East Asian lumbar disc herniation patients. Cell Biochem Biophys. 2014;70(2):1219-1225.
[27] KAMEDA T, ZVICK J, VUK M, et al. Expression and Activity of TRPA1 and TRPV1 in the Intervertebral Disc: association with Inflammation and Matrix Remodeling. Int J Mol Sci. 2019;20(7):1767.
[28] 余盈,叶霖,叶菲.椎间盘再生治疗策略的研究进展[J].华南国防医学杂志,2019,33(4):292-295.
[29] JOHNSON WE, CATERSON B, EISENSTEIN SM, et al. Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 2002;46(10):2658-2664.
[30] MASUDA K. Biological repair of the degenerated intervertebral disc by the injection of growth factors. Eur Spine J. 2008;17 Suppl 4(Suppl 4): 441-451.
[31] 孙阳,李小飞,马胜山,等.富血小板血浆治疗椎间盘退变的研究进展[J].中国脊柱脊髓杂志,2020,30(8):762-766.
[32] ZHANG YS, KHADEMHOSSEINI A. Advances in engineering hydrogels. Science. 2017;356(6337):eaaf3627.
[33] ANNABI N, TAMAYOL A, UQUILLAS JA, et al. 25th anniversary article: rational design and applications of hydrogels in regenerative medicine. Adv Mater. 2014;26(1):85-123.
[34] MOHD ISA IL, ABBAH SA, KILCOYNE M, et al. Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury. Sci Adv. 2018;4(4):eaaq0597.
[35] 俞磊.新型温敏脱细胞髓核基质凝胶的制备及治疗椎间盘退变的研究[D].上海:中国人民解放军海军军医大学,2020.
[36] MITTL PR, PRIESTLE JP, COX DA, et al. The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding. Protein Sci. 1996;5(7):1261-1271.
[37] CHEN S, LIU S, MA K, et al. TGF-β signaling in intervertebral disc health and disease. Osteoarthritis Cartilage. 2019;27(8):1109-1117.
[38] JIN H, SHEN J, WANG B, et al. TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue. FEBS Lett. 2011;585(8):1209-1215.
[39] REZA AT, NICOLL SB. Serum-free, chemically defined medium with TGF-beta(3) enhances functional properties of nucleus pulposus cell-laden carboxymethylcellulose hydrogel constructs. Biotechnol Bioeng. 2010;105(2):384-395.
[40] LIGORIO C, O’BRIEN M, HODSON NW, et al. TGF-β3-loaded graphene oxide -self-assembling peptide hybrid hydrogels as functional 3D scaffolds for the regeneration of the nucleus pulposus. Acta Biomater. 2021;127:116-130.
[41] GAN Y, LI S, LI P, et al. A controlled release codelivery system of MSCs encapsulated in dextran/gelatin hydrogel with TGF-beta3-loaded nanoparticles for nucleus pulposus regeneration. Stem Cells Int. 2016; 2016:9042019.
[42] JIANG C, LI DP, ZHANG ZJ, et al. Effect of basic fibroblast growth factor and transforming growth factor-β1 combined with bone marrow mesenchymal stem cells on the repair of degenerated intervertebral discs in rat models. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015;37(4): 456-465.
[43] GUILLAUME O, DALY A, LENNON K, et al. Shape-memory porous alginate scaffolds for regeneration of the annulus fibrosus: effect of TGF-β3 supplementation and oxygen culture conditions. Acta Biomater. 2014;10(5):1985-1995.
[44] OKADA M, KIM JH, YOON ST, et al. Pulsed Electromagnetic Field (PEMF) plus BMP-2 upregulates intervertebral disc-cell matrix synthesis more than either BMP-2 alone or PEMF alone. J Spinal Disord Tech. 2013; 26(6):E221-E226.
[45] LI Z, LANG G, KARFELD-SULZER LS, et al. Heterodimeric BMP-2/7 for nucleus pulposus regeneration-In vitro and ex vivo studies. J Orthop Res. 2017;35(1):51-60.
[46] PEETERS M, DETIGER SE, KARFELD-SULZER LS, et al. BMP-2 and BMP-2/7 heterodimers conjugated to a fibrin/hyaluronic acid hydrogel in a large animal model of mild intervertebral disc degeneration. Biores Open Access. 2015;4(1):398-406.
[47] HINGERT D, BARRETO HENRIKSSON H, BARANTO A, et al. BMP-3 promotes matrix production in co-cultured stem cells and disc cells from low back pain patients. Tissue Eng Part A. 2020;26(1-2):47-56.
[48] CAWSTON TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther. 1996;70(3):163-182.
[49] GANDHI SD, MAERZ T, MITCHELL S, et al. Intradiscal delivery of anabolic growth factors and a metalloproteinase inhibitor in a rabbit acute lumbar disc injury model. Int J Spine Surg. 2020;14(4):585-589.
[50] 刘龙刚,伍耀宏,陶晖,等.修饰有BMP-7功能片段的功能化自组装多肽纳米纤维水凝胶RADKPS制备及其生物相容性研究[J].中国修复重建外科杂志,2016,30(4):491-498.
[51] GROWNEY EA, LINDER HR, GARG K, et al. Bio-conjugation of platelet-rich plasma and alginate through carbodiimide chemistry for injectable hydrogel therapies. J Biomed Mater Res B Appl Biomater. 2020;108(5):1972-1984.
[52] VADALà G, RUSSO F, MUSUMECI M, et al. Clinically relevant hydrogel-based on hyaluronic acid and platelet rich plasma as a carrier for mesenchymal stem cells: rheological and biological characterization. J Orthop Res. 2017;35(10):2109-2116.
[53] CHOI MH, BLANCO A, STEALEY S, et al. Micro-clotting of platelet-rich plasma upon loading in hydrogel microspheres leads to prolonged protein release and slower microsphere degradation. Polymers (Basel). 2020;12(8):1712.
[54] SAWAMURA K, IKEDA T, NAGAE M, et al. Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A. 2009;15(12):3719-3727.
[55] PAGLIA DN, SINGH H, KARUKONDA T, et al. PDGF-BB delays degeneration of the intervertebral discs in a rabbit preclinical model. Spine (Phila Pa 1976). 2016;41(8):E449-E458.
[56] GANTENBEIN-RITTER B, BENNEKER LM, ALINI M, et al. Differential response of human bone marrow stromal cells to either TGF-β(1) or rhGDF-5. Eur Spine J. 2011;20(6):962-971.
[57] HENRY N, CLOUET J, FRAGALE A, et al. Pullulan microbeads/Si-HPMC hydrogel injectable system for the sustained delivery of GDF-5 and TGF-β1: new insight into intervertebral disc regenerative medicine. Drug Deliv. 2017;24(1):999-1010.
[58] WEI A, SHEN B, WILLIAMS LA, et al. Expression of growth differentiation factor 6 in the human developing fetal spine retreats from vertebral ossifying regions and is restricted to cartilaginous tissues. J Orthop Res. 2016;34(2):279-289.
[59] HODGKINSON T, STENING JZ, WHITE LJ, et al. Microparticles for controlled growth differentiation factor 6 delivery to direct adipose stem cell-based nucleus pulposus regeneration. J Tissue Eng Regen Med. 2019;13(8):1406-1417.
[60] MWALE F, ROUGHLEY P, ANTONIOU J. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage:a requisite for tissue engineering of intervertebral disc. Eur Cell Mater. 2004;8:58-63.
[61] ELLMAN MB, YAN D, AHMADINIA K, et al. Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem. 2013;114(4):735-742.
[62] HäCKEL S, ZOLFAGHAR M, DU J, et al. Fibrin-hyaluronic acid hydrogel (RegenoGel) with fibroblast growth factor-18 for in vitro 3D culture of human and bovine nucleus pulposus cells. Int J Mol Sci. 2019;20(20): 5036.
[63] GONçALVES RM, ANTUNES JC, BARBOSA MA. Mesenchymal stem cell recruitment by stromal derived factor-1-delivery systems based on chitosan/poly(γ-glutamic acid) polyelectrolyte complexes. Eur Cell Mater. 2012;23:249-260.
[64] PEREIRA CL, GONçALVES RM, PEROGLIO M, et al. The effect of hyaluronan-based delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs. Biomaterials. 2014;35(28):8144-8153.
[65] FRAPIN L, CLOUET J, CHéDEVILLE C, et al. Controlled release of biological factors for endogenous progenitor cell migration and intervertebral disc extracellular matrix remodelling. Biomaterials. 2020; 253:120107.
[66] PATTAPPA G, PEROGLIO M, SAKAI D, et al. CCL5/RANTES is a key chemoattractant released by degenerative intervertebral discs in organ culture. Eur Cell Mater. 2014;27:124-136.
[67] OTOSHI K, KIKUCHI S, KATO K, et al. Anti-HMGB1 neutralization antibody improves pain-related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats. Spine (Phila Pa 1976). 2011;36(11):E692-E698.
[68] LIU Y, DU J, PENG P, et al. Regulation of the inflammatory cycle by a controllable release hydrogel for eliminating postoperative inflammation after discectomy. Bioact Mater. 2021;6(1):146-157.
[69] WILLEMS N, YANG HY, LANGELAAN ML, et al. Biocompatibility and intradiscal application of a thermoreversible celecoxib-loaded poly-N-isopropylacrylamide MgFe-layered double hydroxide hydrogel in a canine model. Arthritis Res Ther. 2015;17(1):214.
[70] TELLEGEN AR, WILLEMS N, BEUKERS M, et al. Intradiscal application of a PCLA-PEG-PCLA hydrogel loaded with celecoxib for the treatment of back pain in canines: what’s in it for humans? J Tissue Eng Regen Med. 2018;12(3):642-652.
[71] HWANG MH, KIM KS, YOO CM, et al. Photobiomodulation on human annulus fibrosus cells during the intervertebral disk degeneration: extracellular matrix-modifying enzymes. Lasers Med Sci. 2016;31(4):767-777.
[72] BAI J, ZHANG Y, FAN Q, et al. Reactive oxygen species-scavenging scaffold with rapamycin for treatment of intervertebral disk degeneration. Adv Healthc Mater. 2020;9(3):e1901186.
[73] XU D, JIN H, WEN J, et al. Hydrogen sulfide protects against endoplasmic reticulum stress and mitochondrial injury in nucleus pulposus cells and ameliorates intervertebral disc degeneration. Pharmacol Res. 2017;117:357-369.
[74] ZHENG Z, CHEN A, HE H, et al. pH and enzyme dual-responsive release of hydrogen sulfide for disc degeneration therapy. J Mater Chem B. 2019;7(4):611-618.
[75] CITRI A, YARDEN Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006; 7(7):505-516.
[76] PAN Z, SUN H, XIE B, et al. Therapeutic effects of gefitinib-encapsulated thermosensitive injectable hydrogel in intervertebral disc degeneration. Biomaterials. 2018;160:56-68.
[77] ZHU Y, TAN J, ZHU H, et al. Development of kartogenin-conjugated chitosan-hyaluronic acid hydrogel for nucleus pulposus regeneration. Biomater Sci. 2017;5(4):784-791.
[78] SCHROEDER M, VIEZENS L, SCHAEFER C, et al. Chemokine profile of disc degeneration with acute or chronic pain. J Neurosurg Spine. 2013; 18(5):496-503.
[79] LIKHITPANICHKUL M, KIM Y, TORRE OM, et al. Fibrin-genipin annulus fibrosus sealant as a delivery system for anti-TNFα drug. Spine J. 2015; 15(9):2045-2054.
[80] THAN KD, RAHMAN SU, WANG L, et al. Intradiscal injection of simvastatin results in radiologic, histologic, and genetic evidence of disc regeneration in a rat model of degenerative disc disease. Spine J. 2014;14(6):1017-1028.
[81] FRITH JE, MENZIES DJ, CAMERON AR, et al. Effects of bound versus soluble pentosan polysulphate in PEG/HA-based hydrogels tailored for intervertebral disc regeneration. Biomaterials. 2014;35(4):1150-1162.
[82] CHENG YH, YANG SH, LIN FH. Thermosensitive chitosan-gelatin-glycerol phosphate hydrogel as a controlled release system of ferulic acid for nucleus pulposus regeneration. Biomaterials. 2011;32(29):6953-6961.
[83] NA K, PARK JH, KIM SW, et al. Delivery of dexamethasone, ascorbate, and growth factor (TGF beta-3) in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes. Biomaterials. 2006; 27(35):5951-5957.
[84] BERTOLO A, ETTINGER L, AEBLI N, et al. The in vitro effects of dexamethasone, insulin and triiodothyronine on degenerative human intervertebral disc cells under normoxic and hypoxic conditions. Eur Cell Mater. 2011;21:221-229.
[85] NAKASHIMA S, MATSUYAMA Y, TAKAHASHI K, et al. Regeneration of intervertebral disc by the intradiscal application of cross-linked hyaluronate hydrogel and cross-linked chondroitin sulfate hydrogel in a rabbit model of intervertebral disc injury. Biomed Mater Eng. 2009; 19(6):421-429.
[86] 杨帅,吴晓淋,刘畅,等.干细胞治疗退变性椎间盘疾病的研究进展[J].中国骨与关节杂志,2020,9(7):502-507.
[87] 王宇翔,徐海栋,赵建宁.细胞移植治疗椎间盘退变的研究进展[J].中国矫形外科杂志,2021,29(11):1009-1012.
|